Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis


Autoria(s): Delatycki, B.; Allen, K. J.; Nisselle, A. E.; Collins, V.; Metcalfe, S.; Du Sart, D.; Halliday, J. W.; Aitken, M. A.; Macciocca, I.; Hill, V.; Wakefield, A.; Ritchie, A.; Gason, A.; Nicoll, A. J.; Powell, L. W.; Williamson, R.
Contribuinte(s)

R. Horton

Data(s)

23/07/2005

Resumo

HFE-associated hereditary haemochromatosis is a recessive, iron-overload disorder that affects about one in 200 north Europeans and that can be easily prevented. However, genetic screening for this disease is controversial, and so we assessed whether such screening was suitable for communities. Cheek-brush screening for the Cys282Tyr HFE mutation was offered to individuals in the workplace. Outcomes were assessed by questionnaires before and after testing. 11307 individuals were screened. We recorded no increase in anxiety. in individuals who were homozygous for the Cys282Tyr mutation or non-homozygous. Self-reported tiredness before testing was significantly higher in homozygous participants than in non-homozygous participants (chi(2) test, p=0.029). Of the 47 homozygous individuals identified, 46 have taken steps to treat or prevent iron accumulation. Population genetic screening for HFE-associated hereditary haemochromatosis can be practicable and acceptable.

Identificador

http://espace.library.uq.edu.au/view/UQ:75757

Idioma(s)

eng

Publicador

The Lancet Publishing Group

Palavras-Chave #Medicine, General & Internal #Penetrance #C1 #321011 Medical Genetics #111716 Preventive Medicine #110311 Medical Genetics (excl. Cancer Genetics)
Tipo

Journal Article